You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Primary Myelofibrosis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Real World Evidence of Fedratinib Effectiveness in MF

Not yet recruiting
  • Primary Myelofibrosis
  • +2 more
  • (no location specified)
May 22, 2023

Myelofibrosis Trial (Momelotinib)

Available
  • Myelofibrosis
  • (no location specified)
Oct 12, 2022

Pre-fibrotic Myelofibrosis Trial in Taipei, Taiwan, 100 (Ropeginterferon Alfa-2B Prefilled Syringe [Besremi])

Recruiting
  • Pre-fibrotic Myelofibrosis
  • Ropeginterferon Alfa-2B Prefilled Syringe [Besremi]
  • Taipei, Taiwan, 100, Taiwan
    National Taiwan University Hospital
Feb 7, 2023

Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

Recruiting
  • Myeloproliferative Neoplasm
  • +7 more
    • Hong Kong, Hong Kong
      Department of Medicine, Queen Mary Hospital
    May 21, 2023

    Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis, Secondary Myelofibrosis Trial in Houston

    Completed
    • Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
    • +2 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    May 27, 2022

    Ruxolitinib in Patients With Myelofibrosis

    Not yet recruiting
    • Myelofibrosis
    • (no location specified)
    Feb 28, 2023

    Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)

    Recruiting
    • Primary Myelofibrosis
    • +4 more
    • New York, New York
      Ruttenberg Treatment Center
    Jul 18, 2022

    Myelofibrosis Trial in Canton (Jaktinib Hydrochloride Tablet)

    Recruiting
    • Myelofibrosis
    • Jaktinib Hydrochloride Tablet
    • Canton, Ohio
      Site 01
    Aug 18, 2022

    Assess Real-World Patient-Reported Outcomes With Fedratinib for

    Recruiting
    • Myelofibrosis
      • City, State, Austria
        Local Institution
      Dec 16, 2022

      Myelofibrosis Trial in Paris (Ruxolotinib)

      Completed
      • Myelofibrosis
      • Paris, France
        ROBIN
      Jul 26, 2022

      Myelofibrosis Trial in France (Clonal architecture determination)

      Not yet recruiting
      • Myelofibrosis
      • Clonal architecture determination
      • Angers, France
      • +6 more
      Jan 24, 2023

      Myelofibrosis, Moderate Thrombocytopenia Trial (Selinexor)

      Not yet recruiting
      • Myelofibrosis
      • Moderate Thrombocytopenia
      • (no location specified)
      Jul 31, 2023

      Myelofibrosis Trial in Salt Lake City (Pegylated interferon alpha2a)

      Not yet recruiting
      • Myelofibrosis
      • Pegylated interferon alpha2a
      • Salt Lake City, Utah
        Huntsman Cancer Institute at the University of Utah
      Sep 6, 2022

      Primary Myelofibrosis, Secondary Myelofibrosis Trial in Greifswald, Halle (Saale) (Fedratinib Oral Capsule [Inrebic], Nivolumab)

      Recruiting
      • Primary Myelofibrosis
      • Secondary Myelofibrosis
      • Greifswald, Germany
      • +1 more
      Jun 15, 2022

      Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis

      Terminated
      • Primary Myelofibrosis (PMF)
      • +2 more
      • Larkspur, California
      • +2 more
      Nov 14, 2022

      Myelofibrosis; Anemia, Anemia, Myelofibrosis Trial in Canton, Gettysburg (DISC-0974)

      Recruiting
      • Myelofibrosis; Anemia
      • +5 more
      • Jacksonville, Florida
      • +6 more
      Jan 3, 2023

      Myeloproliferative Tumor, Essential Thrombocythemia, Primary Myelofibrosis, Prefibrotic Stage Trial (CALR allele burden

      Recruiting
      • Myeloproliferative Neoplasm
      • +3 more
      • CALR allele burden quantification
      • Angers, France
        CHU Angers
      Nov 2, 2022

      Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

      Not yet recruiting
      • Myelofibrosis (PMF)
      • +2 more
      • New York, New York
        Ruttenberg Treatment Center
      Apr 18, 2023

      Ruxolitinib in Patients With Myelofibrosis

      Completed
      • Myelofibrosis
      • (no location specified)
      Jun 5, 2022

      Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Myelofibrosis Transformation in Essential Thrombocythemia,

      Recruiting
      • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 18, 2022

      Myelofibrosis Trial in United States (Ruxolitinib)

      Recruiting
      • Myelofibrosis
      • Boston, Massachusetts
      • +4 more
      Oct 21, 2022

      Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Ipoh (NS-018,

      Recruiting
      • Primary Myelofibrosis
      • +2 more
      • Worcester, Massachusetts
      • +16 more
      Oct 31, 2022

      Myelofibrosis Trial in Saint Louis (Fostamatinib, Ruxolitinib)

      Recruiting
      • Myelofibrosis
      • Saint Louis, Missouri
        Washington University School of Medicine
      Oct 26, 2022

      Myelofibrosis Trial in Hong Kong (Bomedemstat)

      Recruiting
      • Myelofibrosis
      • Hong Kong, Hong Kong
        Department of Medicine, the University of Hong Kong, Queen Mary
      Oct 3, 2022

      Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in United States

      Completed
      Has Results
      • Primary Myelofibrosis
      • +2 more
      • Scottsdale, Arizona
      • +8 more
      Feb 10, 2022